Intellia Therapeutics Inc buy Bank of America Co.
Start price
27.10.25
/
50%
€12.81
Target price
27.10.26
€25.78
Performance (%)
-17.88%
Price
17:16
€10.52
Summary
This prediction is currently active. The price of Intellia Therapeutics Inc has decreased since the start of the prediction. Compared to the start price this results in a performance of -17.88%. This prediction currently runs until 27.10.26. The prediction end date can be changed by Bank_of_America_Co_ at any time. Bank_of_America_Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Intellia Therapeutics Inc | 5.906% | 5.906% |
| iShares Core DAX® | 0.184% | 5.072% |
| iShares Nasdaq 100 | -0.770% | -2.079% |
| iShares Nikkei 225® | 0.733% | -3.346% |
| iShares S&P 500 | -0.166% | 0.904% |
Comments by Bank_of_America_Co_ for this prediction
In the thread Intellia Therapeutics Inc diskutieren
Intellia Therapeutics (NASDAQ:NTLA) had its price target lowered by analysts at Bank of America Corporation from $36.00 to $30.00. They now have a "buy" rating on the stock.
Ratings data for NTLA provided by MarketBeat